Integral Health Asset Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-31,311
Closed -$5.54M 84
2022
Q2
$5.54M Sell
31,311
-18,689
-37% -$2.69M 1.14% 32
2022
Q1
$7.2M Buy
+50,000
New +$6.76M 1.87% 18
2021
Q4
Sell
-40,000
Closed -$6.79M 88
2021
Q3
$6.79M Buy
+40,000
New +$6.23M 1.95% 15
2020
Q3
Sell
-45,000
Closed -$7.65M 88
2020
Q2
$7.65M Buy
+45,000
New +$6.71M 2.29% 17
2020
Q1
Sell
-30,000
Closed -$3.43M 78
2019
Q4
$3.43M Buy
+30,000
New +$3.18M 1.33% 26

Other funds holding SGEN

Integral Health Asset Management's SGEN Position: Q3 2022 in Review

Integral Health Asset Management sold out of Seagen Inc. Common Stock (SGEN) in Q3 2022, closing a stake of 31,311 shares — an estimated $5.54M sold.

Integral Health Asset Management first reported a position in SGEN in Q4 2019 and held it in 5 quarters. The position peaked at $7.65M in Q2 2020. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

  • Integral Health Asset Management reported no remaining Seagen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Integral Health Asset Management sold 31,311 Seagen Inc. Common Stock shares in Q3 2022, an estimated $5.54M.
  • Integral Health Asset Management first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Integral Health Asset Management's Seagen Inc. Common Stock position peaked at $7.65M in Q2 2020.
  • 539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Integral Health Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.